FDA Draft Guidance Points Upward For OTC Wellness Device Development
This article was originally published in The Tan Sheet
Executive Summary
The decision algorithm and flexible approach in a draft guidance on general wellness products will support innovative mobile health development, an industry advocate says. FDA does not intend to review low-risk OTC products, such as exercise equipment, that claim to support various facets of patients' wellness.
You may also be interested in...
Combo Products Guidance Could Help Point Novel OTC Switches In Right Direction
FDA delivers a draft GMPs guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device products. The document could be useful for firms interested in proposing novel Rx-to-OTC switches.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.